← All diseases
Infectious diseases
Chronic hepatitis B
Do you want to receive a message when there is new research about Chronic hepatitis B? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication there is one sentence that explains what was investigated — and you receive a message as soon as there is new research about Chronic hepatitis B. View what Premium costs.
Publications and studies (2004)
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Examining the Influencing Factors of Chronic Hepatitis B Monitoring Behaviors among Asian Americans: Application of the Information-Motivation-Behavioral Model. (2022/04/12) ♡
- Average corticosteroid dose and risk for HBV reactivation and hepatitis flare in patients with resolved hepatitis B infection. (2022/04/01) ♡
- Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis. (2022/04/01) ♡
- Comparison of superb microvascular imaging and shear wave elastography for assessing liver fibrosis in chronic hepatitis B. (2022/04/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sequential HBV treatment with tenofovir alafenamide for patients with chronic hepatitis B: week 96 results from a real-world, multicenter cohort study. (2022/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report. (2022/03/31) ♡
- Hepatitis B virus infection and the risk of gastrointestinal cancers among Chinese population: A prospective cohort study. (2022/03/15) ♡
- Non-invasive Assessment of Subclinical Renal Parenchymal Changes in Chronic Hepatitis B Virus By T1 Mapping Magnetic Resonance Imaging. (2022/03/14) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Withdrawal of Nucleos(t)ide Analogues in the Treatment of Chronic Hepatitis B: A Cornelian Choice. (2022/03/01) ♡
- Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis. (2022/03/01) ♡
- Screening for hepatocellular carcinoma among adults with HIV/HBV co-infection in Zambia: a pilot study. (2022/03/01) ♡
- Construction of an anti-hepatitis B virus preS1 antibody and usefulness of preS1 measurement for chronic hepatitis B patients: Anti-HBV PreS1 antibody. (2022/03/01) ♡
- Multi-scale information with attention integration for classification of liver fibrosis in B-mode US image. (2022/03/01) ♡
- Autonomic impairment in treatment-naive patients with chronic hepatitis B and C infections. (2022/03/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice. (2022/02/28) ♡
- Effectiveness of Tenofovir Alafenamide in Chronic Hepatitis B Patients with Normal Alanine Aminotransferase and Positive Hepatitis B Virus DNA. (2022/02/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis. (2022/02/28) ♡
- TIGIT Signaling Pathway Regulates Natural Killer Cell Function in Chronic Hepatitis B Virus Infection. (2022/02/21) ♡
- Detection of the Hepatitis B Surface Antigen in Patients with Occult Hepatitis B by Use of an Assay with Enhanced Sensitivity. (2022/02/16) ♡
- 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators. (2022/02/15) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of a 12-week home-based exercise training program on aerobic capacity, muscle mass, liver and spleen stiffness, and quality of life in cirrhotic patients: a randomized controlled clinical trial. (2022/02/14) ♡
- Metabolic Disorders in Patients with Chronic Hepatitis B Virus Infection: Coffee as a Panacea? (ANRS CO22 Hepather Cohort). (2022/02/14) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Translational Strategies to Eliminate Chronic Hepatitis B in Children: Prophylaxis and Management in East Asian Countries. (2022/02/04) ♡
- Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression. (2022/02/01) ♡
- Transforming growth factor-β: An early predictor of a functional cure in chronic hepatitis B treated with interferon. (2022/02/01) ♡
- High levels of soluble programmed death-1 are associated with virological response in chronic hepatitis B patients after antiviral treatment. (2022/02/01) ♡
- Sexual Dysfunction in Patients with Chronic Hepatitis B: Prevalence and Risk Factors. (2022/02/01) ♡
- The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis B. (2022/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of gut microbiota in hepatitis B disease progression and treatment. (2022/02/01) ♡
- Optimizing hepatitis B virus screening in the United States using a simple demographics-based model. (2022/02/01) ♡
- Progression of liver fibrosis and associated factors among chronic hepatitis B patients at a general hospital in Northern Vietnam. (2022/02/01) ♡
- Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC. (2022/01/20) ♡
- Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients. (2022/01/17) ♡
- Safety and Efficacy of Tenofovir Alafenamide Fumarate in Early-Middle Pregnancy for Mothers With Chronic Hepatitis B. (2022/01/17) ♡
- Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation. (2022/01/07) ♡
- Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19. (2022/01/07) ♡
- Risk Factors Associated With Quality of Life in Patients With Hepatitis B Virus Related Cirrhosis. (2022/01/06) ♡
- Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B. (2022/01/04) ♡
- Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018. (2022/01/04) ♡
- A Primary Screening Method for Liver Cancer in Chronic Hepatitis B Carriers: A Prospective Community-Based Cohort Study. (2022/01/03) ♡
- Novel X gene point mutations in chronic hepatitis B and HBV related cirrhotic patients. (2022/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A case of reactivation of hepatitis B presenting with exudative ascites. (2022/01/01) ♡
- The changing epidemiology of hepatocellular carcinoma in Greece. (2022/01/01) ♡
- Interleukin-18 Plays a Positive Feedback Activity to Natural Killer-Like B Cells in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure. (2022/01/01) ♡
- Epidemiology, Genotyping, Mutational and Phylogenetic Analysis of Hepatitis B Virus Infection in North-east India. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia. (2022/01/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. [Meta-analysis of efficacy and safety of Liuwei Wuling Tablets combined with conventional drugs in treatment of liver fibrosis and cirrhosis in chronic hepatitis B]. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. (2022/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Letter: hepatic steatosis in chronic hepatitis B-viral, metabolic or treatment-related? (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome. (2022/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.